Загрузка...
IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way
BACKGROUND: Insulin-like growth factor 2 (IGF2) messenger RNA binding protein 3 (IMP3) has been testified to be overexpressed in prostate cancer and strongly related to patients’ poor prognosis. However, the functions of IMP3 and the underlying mechanisms in prostate cancer still remain unknown. The...
Сохранить в:
| Опубликовано в: : | J Exp Clin Cancer Res |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7493339/ https://ncbi.nlm.nih.gov/pubmed/32938489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01657-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|